Abstract:Introduction: Glioblastoma multiforme (GBM) poses a significant challenge in terms of treatment due to its high malignancy, necessitating the identification of additional molecular targets. VSIG4, an oncogenic gene participates in tumor growth and migration in various cancer types. Nevertheless, the precise process through which VSIG4 facilitates the malignant progression of glioma remains to be elucidated. Objectives: This research aims to explore the function and molecular mechanism involving VSIG4 in the malignant progression of glioma. Methods: The amount of VSIG4 was measured using qPCR, western blotting, and immunohistochemistry. Lentivirus infections were applied for upregulating or downregulating molecules within glioma cells. The incorporation of 5-ethynyl-20-deoxyuridine, Transwell, cell counting kit-8, and clone formation experiments, were applied to assess the biological functions of molecules on glioma cells. Dual luciferase reporter gene, RNA immunoprecipitation, and chromatin immunoprecipitation assays were used to explore the functional relationship among relevant molecules. Results: The upregulation of VSIG4 was observed in GBM tissues, indicating an adverse prognosis. Silencing VSIG4 in glioma cells resulted in a decrease in cell viability, invasion, proliferation, and tumorigenesis, an increase in cell apoptosis, and a stagnation in the cell cycle progression at the G0/G1 phase. Mechanistically, SPI1-mediated upregulation of VSIG4 expression led to binding between VSIG4 and THBS1 protein, ultimately facilitating the malignant progression of glioma cells through the activation of the PI3K/AKT pathway. The inhibited proliferative and invasive capabilities of glioma cells were reversed by overexpressing THBS1 following the knockdown of VSIG4. Conclusion: Our findings provide evidence for the role of VSIG4 as an oncogene and reveal the previously unidentified contribution of the SPI1/VSIG4/THBS1 axis in the malignant progression of glioma. This signaling cascade enhances tumor growth and invasion by modulating the PI3K/AKT pathway. VSIG4 as a potential biomarker may be a viable strategy in the development of tailored molecular therapies for GBM.

Human Sperm-Associated Antigen 4 As a Potential Biomarker of Glioblastoma Progression and Prognosis.

Sperm‑associated Antigen 4 (SPAG4) As a New Cancer Marker Interacts with Nesprin3 to Regulate Cell Migration in Lung Carcinoma.

The Expression of SALL4 in Patients with Gliomas: High Level of SALL4 Expression is Correlated with Poor Outcome

Sperm Associated Antigen 4 Promotes SREBP1-mediated De Novo Lipogenesis Via Interaction with Lamin A/C and Contributes to Tumor Progression in Hepatocellular Carcinoma

A comprehensive pan-cancer analysis revealing SPAG6 as a novel diagnostic, prognostic and immunological biomarker in tumor

Identification of Novel Human Glioblastoma-Specific Transcripts by Serial Analysis of Gene Expression Data Mining

Pan-cancer analysis: SPAG5 is an immunological and prognostic biomarker for multiple cancers

AGBL4 promotes malignant progression of glioblastoma via modulation of MMP-1 and inflammatory pathways

APOL4, a Novel Immune-Related Prognostic Biomarker for Glioma

TSPAN4 influences glioblastoma progression through regulating EGFR stability

SPAG9 Promotes Prostate Cancer Growth and Metastasis

PLEKHA4 promotes glioblastoma progression through apoptosis inhibition, tumor cell migration, and macrophage infiltration

MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients

Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers

Hypoxia regulates the sperm associated antigen 4 (SPAG4) via HIF, which is expressed in renal clear cell carcinoma and promotes migration and invasion in vitro

The role of SPI1/VSIG4/THBS1 on glioblastoma progression through modulation of the PI3K/AKT pathway

Ubiquitin-specific protease 4 promotes glioblastoma multiforme via activating ERK pathway

Upregulation of SPAG6 in Myelodysplastic Syndrome: Knockdown Inhibits Cell Proliferation Via AKT/FOXO Signaling Pathway.

Regulation of LARP4 in Malignant Biological Behavior of GBM

Identification of Four Enhancer-Associated Genes As Risk Signature for Diffuse Glioma Patients

Integrated Analysis Reveals Prognostic Value and Mesenchymal Identity Suppression by Glycoprotein M6B in Glioma.